
    
      The Investigator will evaluate the safety and efficacy of a 4-weeks treatment with sodium
      phenylbutyrate in patients with pyruvate dehydrogenase complex deficiency. Efficacy will be
      evaluated based on biochemical endpoints (blood lactate and pyruvate).
    
  